The development and use of biologic drugs – such as Herceptin and Mabthera – has revolutionised the treatment of many cancers, and biological medicines now make up the largest spending area in the NHS medicines budget. read more
The British Journal of Cancer has published a study that examines the association between sedentary behaviour and increased bowel cancer risk in men.
Researchers publishing in Cell report that injecting mice with inactivated induced pluripotent stem cells launched an immune response against breast, lung, and skin cancers. read more
A study, published in the BMJ, reports a possible association between intake of highly processed food in the diet and cancer.
read more
A new study, in Nature Biotechnology, investigates the use of nanorobots to shrink tumours by cutting off their blood supply.
Researchers examined whether high-temperature tea drinking, along with the established risk factors of alcohol consumption and smoking, is associated with esophageal cancer risk, in a study, published in the Annals of Internal Medicine. read more
A new study, published in Science, describes a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA.
A new study, published in the Annals of Oncology, shows a drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. read more
In a large prospective cohort study, researchers examine the association between Glyphosate use and cancer incidence, published in the Journal of the National Cancer Institute.
read more
Publishing in Gut, researchers report that long term use of proton pump inhibitors (PPIs) is linked to a more than doubling in the risk of developing stomach cancer. read more
The BMJ has published a study investigating the effectiveness of cancer drugs approved by the European Medicines Agency (EMA).
In a new study, published in JAMA, scientists report that among postmenopausal women, hormone therapy was not associated with risk of all-cause, cardiovascular, or cancer mortality during a cumulative follow-up of 18 years.
read more
In a new study, published in JAMA, scientists report that among postmenopausal women, hormone therapy was not associated with risk of … read more
At the American Society of Clinical Oncology (ASCO), scientists presented results from an early clinical trial of an ovarian cancer drug that could potentially shrink tumours. read more
Publishing in Cell, researchers have looked at the effect of aldehyde exposure on DNA repair, reporting that aldehydes trigger degradation of a protein involved in the repair process. read more
The Cancer Drugs Fund (CDF) was launched in England in 2010 to provide patients with access to anti-cancer drugs not available through the NHS because the drugs had not been appraised, were in the process of being appraised, or had been appraised but not recommended by the National Institute of Health and Care Excellence (NICE). read more
The International Agency for Research on Cancer (IARC) has published it’s audit of worldwide childhood cancer rates in the Lancet Oncology. read more
Researchers publishing in Gut report long-term antibiotic use in early-to-middle adulthood was associated with increased risk of colorectal adenoma – the precursor for some colorectal cancers. read more
Publishing in Science a group of researchers studied the relationship between the number of normal stem cell divisions and the risk of 17 cancer types in 69 countries. They reported a strong correlation between cancer incidence and normal stem cell divisions in all countries, regardless of their environment. read more
The National Institute for Health and Care Excellence (NICE) has published new guidance which recommends Cetuximab and panitumumab, for previously untreated metastatic colorectal cancer, be moved from the Cancer Drugs Fund into routine use. read more
